Cargando…

CEMIP as a potential biomarker and therapeutic target for breast cancer patients

Purpose: We aimed to evaluate whether CEMIP plays any role in the survival outcome of breast cancer (BC) patients, as well as to explore the regulatory mechanism of CEMIP in BC. Methods: We evaluated the expression and prognostic effect of CEMIP in BC patients using the Oncomine, GEPIA, UALCAN, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Jinqi, Zhu, Xudong, Qiao, Xinbo, Wang, Yulun, Bu, Jiawen, Zhang, Xiaoying, Ma, Qingtian, Liang, Lu, Sun, Lisha, Liu, Caigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964326/ https://www.ncbi.nlm.nih.gov/pubmed/35370456 http://dx.doi.org/10.7150/ijms.58067

Ejemplares similares

HCK can serve as novel prognostic biomarker and therapeutic target for Breast Cancer patients
por: Zhu, Xudong, et al.
Publicado: (2020)

KK-LC-1 as a therapeutic target to eliminate ALDH(+) stem cells in triple negative breast cancer
por: Bu, Jiawen, et al.
Publicado: (2023)

Targeting SOST using a small-molecule compound retards breast cancer bone metastasis
por: Sun, Lisha, et al.
Publicado: (2022)

KCNJ15 deficiency promotes drug resistance via affecting the function of lysosomes
por: Qiao, Xinbo, et al.
Publicado: (2023)

Central Role of CEMIP in Tumorigenesis and Its Potential as Therapeutic Target
por: Li, Li, et al.
Publicado: (2017)

LIPH promotes metastasis by enriching stem‐like cells in triple‐negative breast cancer
por: Zhang, Yixiao, et al.
Publicado: (2020)

CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer
por: Xing, Fei, et al.
Publicado: (2023)

Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2(+)HR(+) breast cancer
por: Bu, Jiawen, et al.
Publicado: (2023)

Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer
por: Zhang, Yixiao, et al.
Publicado: (2022)

Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis
por: Qiao, Xinbo, et al.
Publicado: (2021)

Research on the biological mechanism and potential application of CEMIP
por: Liu, Yang, et al.
Publicado: (2023)

Neoadjuvant Chemotherapy Plays an Adverse Role in the Prognosis of Grade 2 Breast Cancer
por: Zhu, Xudong, et al.
Publicado: (2019)

The altering in sensory sensitivity: a current issue of female breast surgery
por: Zhu, Tong, et al.
Publicado: (2022)

FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis
por: Zhang, Yixiao, et al.
Publicado: (2020)

Clinical Implications of HSC70 Expression in Clear Cell Renal Cell Carcinoma
por: Zhang, Yixiao, et al.
Publicado: (2021)

High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic Biomarker
por: Dong, Xingxing, et al.
Publicado: (2021)

CEMIP upregulates BiP to promote breast cancer cell survival in hypoxia
por: Banach, Anna, et al.
Publicado: (2019)

CEMIP, a Promising Biomarker That Promotes the Progression and Metastasis of Colorectal and Other Types of Cancer
por: Domanegg, Kevin, et al.
Publicado: (2022)

Induction of CEMIP in Chondrocytes by Inflammatory Cytokines: Underlying Mechanisms and Potential Involvement in Osteoarthritis
por: Ohtsuki, Takashi, et al.
Publicado: (2020)

Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2014)

Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases
por: Liu, Mingyu, et al.
Publicado: (2023)

NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer
por: Zeng, Taofei, et al.
Publicado: (2022)

Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer
por: Shen, Yanyan, et al.
Publicado: (2022)

CircCEMIP promotes anoikis-resistance by enhancing protective autophagy in prostate cancer cells
por: Yu, Ying, et al.
Publicado: (2022)

CEMIP promotes extracellular matrix‐detached prostate cancer cell survival by inhibiting ferroptosis
por: Liu, Bing, et al.
Publicado: (2022)

CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes
por: Deroyer, Céline, et al.
Publicado: (2019)

CEMIP (KIAA1199) regulates inflammation, hyperplasia and fibrosis in osteoarthritis synovial membrane
por: Deroyer, Céline, et al.
Publicado: (2022)

CEMIP Promotes Osteosarcoma Progression and Metastasis Through Activating Notch Signaling Pathway
por: Cheng, Jun, et al.
Publicado: (2022)

Loss of REST in breast cancer promotes tumor progression through estrogen sensitization, MMP24 and CEMIP overexpression
por: Cloud, Ashley S., et al.
Publicado: (2022)

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer
por: Zhang, Hao, et al.
Publicado: (2020)

Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation
por: Zhang, Biying, et al.
Publicado: (2023)

Induction of KIAA1199/CEMIP is associated with colon cancer phenotype and poor patient survival
por: Fink, Stephen P., et al.
Publicado: (2015)

Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer
por: Lee, Hee Seung, et al.
Publicado: (2018)

Hyaluronan Degradation by Cemip Regulates Host Defense against Staphylococcus aureus Skin Infection
por: Dokoshi, Tatsuya, et al.
Publicado: (2020)

Hypoxia increases KIAA1199/CEMIP expression and enhances cell migration in pancreatic cancer
por: Oba, Takuya, et al.
Publicado: (2021)

Targeting KK-LC-1 inhibits malignant biological behaviors of triple-negative breast cancer
por: Zhu, Xudong, et al.
Publicado: (2023)

ATF4/CEMIP/PKCα promotes anoikis resistance by enhancing protective autophagy in prostate cancer cells
por: Yu, Ying, et al.
Publicado: (2022)

Hypoxia promotes colon cancer dissemination through up-regulation of cell migration-inducing protein (CEMIP)
por: Evensen, Nikki A., et al.
Publicado: (2015)

Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Correction: Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_afd3pr9bvss7001gtq0r3conct